190 related articles for article (PubMed ID: 37986008)
1. Pretreatment patient-specific quality assurance prediction based on 1D complexity metrics and 3D planning dose: classification, gamma passing rates, and DVH metrics.
Chen L; Luo H; Li S; Tan X; Feng B; Yang X; Wang Y; Jin F
Radiat Oncol; 2023 Nov; 18(1):192. PubMed ID: 37986008
[TBL] [Abstract][Full Text] [Related]
2. Efficient dose-volume histogram-based pretreatment patient-specific quality assurance methodology with combined deep learning and machine learning models for volumetric modulated arc radiotherapy.
Gong C; Zhu K; Lin C; Han C; Lu Z; Chen Y; Yu C; Hou L; Zhou Y; Yi J; Ai Y; Xiang X; Xie C; Jin X
Med Phys; 2022 Dec; 49(12):7779-7790. PubMed ID: 36190117
[TBL] [Abstract][Full Text] [Related]
3. Machine learning-generated decision boundaries for prediction and exploration of patient-specific quality assurance failures in stereotactic radiosurgery plans.
Braun J; Quirk S; Tchistiakova E
Med Phys; 2022 Mar; 49(3):1955-1963. PubMed ID: 35064564
[TBL] [Abstract][Full Text] [Related]
4. Prediction of patient-specific quality assurance for volumetric modulated arc therapy using radiomics-based machine learning with dose distribution.
Ishizaka N; Kinoshita T; Sakai M; Tanabe S; Nakano H; Tanabe S; Nakamura S; Mayumi K; Akamatsu S; Nishikata T; Takizawa T; Yamada T; Sakai H; Kaidu M; Sasamoto R; Ishikawa H; Utsunomiya S
J Appl Clin Med Phys; 2024 Jan; 25(1):e14215. PubMed ID: 37987544
[TBL] [Abstract][Full Text] [Related]
5. Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
Zhen H; Nelms BE; Tome WA
Med Phys; 2011 Oct; 38(10):5477-89. PubMed ID: 21992366
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of dose-volume histogram prediction for organ-at risk and planning target volume based on machine learning.
Jiao SX; Wang ML; Chen LX; Liu XW
Sci Rep; 2021 Feb; 11(1):3117. PubMed ID: 33542427
[TBL] [Abstract][Full Text] [Related]
7. Using deep learning to predict beam-tunable Pareto optimal dose distribution for intensity-modulated radiation therapy.
Bohara G; Sadeghnejad Barkousaraie A; Jiang S; Nguyen D
Med Phys; 2020 Sep; 47(9):3898-3912. PubMed ID: 32621789
[TBL] [Abstract][Full Text] [Related]
8. Dependency of planned dose perturbation (PDP) on the spatial resolution of MapCHECK 2 detectors.
Keeling VP; Ahmad S; Algan O; Jin H
J Appl Clin Med Phys; 2014 Jan; 15(1):4457. PubMed ID: 24423843
[TBL] [Abstract][Full Text] [Related]
9. Attention-aware 3D U-Net convolutional neural network for knowledge-based planning 3D dose distribution prediction of head-and-neck cancer.
Osman AFI; Tamam NM
J Appl Clin Med Phys; 2022 Jul; 23(7):e13630. PubMed ID: 35533234
[TBL] [Abstract][Full Text] [Related]
10. Patient-specific quality assurance failure prediction with deep tabular models.
Levin R; Aravkin AY; Kim M
Biomed Phys Eng Express; 2023 May; 9(4):. PubMed ID: 37141866
[No Abstract] [Full Text] [Related]
11. Comparison of gamma index based on dosimetric error and clinically relevant dose-volume index based on three-dimensional dose prediction in breast intensity-modulated radiation therapy.
Kaneko A; Sumida I; Mizuno H; Isohashi F; Suzuki O; Seo Y; Otani K; Tamari K; Ogawa K
Radiat Oncol; 2019 Feb; 14(1):36. PubMed ID: 30808377
[TBL] [Abstract][Full Text] [Related]
12. Knowledge-based adaptive planning quality assurance using dosimetric indicators for stereotactic adaptive radiotherapy for pancreatic cancer.
Forghani F; Ginn JS; Schiff JP; Zhu T; Marut L; Laugeman E; Maraghechi B; Badiyan SN; Samson PP; Kim H; Robinson CG; Hugo GD; Henke LE; Price AT
Radiother Oncol; 2023 May; 182():109603. PubMed ID: 36889595
[TBL] [Abstract][Full Text] [Related]
13. Site-agnostic 3D dose distribution prediction with deep learning neural networks.
Mashayekhi M; Tapia IR; Balagopal A; Zhong X; Barkousaraie AS; McBeth R; Lin MH; Jiang S; Nguyen D
Med Phys; 2022 Mar; 49(3):1391-1406. PubMed ID: 35037276
[TBL] [Abstract][Full Text] [Related]
14. Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy.
Han C; Zhang J; Yu B; Zheng H; Wu Y; Lin Z; Ning B; Yi J; Xie C; Jin X
Radiat Oncol; 2023 Jul; 18(1):116. PubMed ID: 37434171
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 4-Hz log files and secondary Monte Carlo dose calculation as patient-specific quality assurance for VMAT prostate plans.
Szeverinski P; Kowatsch M; Künzler T; Meinschad M; Clemens P; DeVries AF
J Appl Clin Med Phys; 2021 Jul; 22(7):235-244. PubMed ID: 34151502
[TBL] [Abstract][Full Text] [Related]
16. Patient-specific quality assurance prediction models based on machine learning for novel dual-layered MLC linac.
Zhu H; Zhu Q; Wang Z; Yang B; Zhang W; Qiu J
Med Phys; 2023 Feb; 50(2):1205-1214. PubMed ID: 36342293
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of volumetric modulated arc therapy patient specific QA results to multileaf collimator errors and correlation to dose volume histogram based metrics.
Coleman L; Skourou C
Med Phys; 2013 Nov; 40(11):111715. PubMed ID: 24320423
[TBL] [Abstract][Full Text] [Related]
18. Deep learning method for prediction of patient-specific dose distribution in breast cancer.
Ahn SH; Kim E; Kim C; Cheon W; Kim M; Lee SB; Lim YK; Kim H; Shin D; Kim DY; Jeong JH
Radiat Oncol; 2021 Aug; 16(1):154. PubMed ID: 34404441
[TBL] [Abstract][Full Text] [Related]
19. Using a novel dose QA tool to quantify the impact of systematic errors otherwise undetected by conventional QA methods: clinical head and neck case studies.
Chan MF; Li J; Schupak K; Burman C
Technol Cancer Res Treat; 2014 Feb; 13(1):57-67. PubMed ID: 23819494
[TBL] [Abstract][Full Text] [Related]
20. DVH analysis using a transmission detector and model-based dose verification system as a comprehensive pretreatment QA tool for VMAT plans: Clinical experience and results.
Mohamed Yoosuf AB; AlShehri S; Alhadab A; Alqathami M
J Appl Clin Med Phys; 2019 Nov; 20(11):80-87. PubMed ID: 31605456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
